BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q1 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,838,527 | -19.6% | 976,116 | -2.9% | 0.04% | -15.7% |
| Q2 2023 | $45,806,616 | +109903.6% | 1,005,413 | -2.1% | 0.05% | 0.0% |
| Q1 2023 | $41,641 | -17.3% | 1,026,656 | +3.9% | 0.05% | -25.0% |
| Q4 2022 | $50,369 | -99.9% | 988,205 | +3.3% | 0.07% | -11.7% |
| Q3 2022 | $51,500,000 | -17.8% | 956,182 | -1.9% | 0.08% | -15.4% |
| Q2 2022 | $62,615,000 | -1.1% | 974,863 | +19.4% | 0.09% | +11.0% |
| Q1 2022 | $63,318,000 | -6.3% | 816,579 | +3.8% | 0.08% | -1.2% |
| Q4 2021 | $67,548,000 | +9.3% | 786,909 | +2.4% | 0.08% | -1.2% |
| Q3 2021 | $61,790,000 | -0.7% | 768,240 | -0.6% | 0.08% | +2.4% |
| Q2 2021 | $62,214,000 | -9.8% | 772,844 | -5.5% | 0.08% | -12.8% |
| Q1 2021 | $69,002,000 | -1.2% | 818,145 | -6.0% | 0.09% | -2.1% |
| Q4 2020 | $69,822,000 | -9.9% | 870,169 | -9.7% | 0.10% | -20.7% |
| Q3 2020 | $77,490,000 | -5.6% | 963,563 | +1.1% | 0.12% | -11.7% |
| Q2 2020 | $82,061,000 | +8.7% | 953,086 | +2.5% | 0.14% | -13.3% |
| Q1 2020 | $75,507,000 | -0.4% | 930,006 | +2.6% | 0.16% | +24.4% |
| Q4 2019 | $75,823,000 | -3.9% | 906,762 | +0.5% | 0.13% | -11.8% |
| Q3 2019 | $78,881,000 | +8.0% | 901,808 | +1.1% | 0.14% | +5.1% |
| Q2 2019 | $73,027,000 | +4.1% | 891,660 | +3.3% | 0.14% | +0.7% |
| Q1 2019 | $70,176,000 | +22.3% | 863,071 | -1.0% | 0.14% | +8.8% |
| Q4 2018 | $57,358,000 | -12.4% | 871,432 | +2.6% | 0.12% | -0.8% |
| Q3 2018 | $65,486,000 | +3.2% | 849,481 | -1.2% | 0.13% | -1.6% |
| Q2 2018 | $63,478,000 | +11.2% | 859,668 | -2.1% | 0.13% | +7.6% |
| Q1 2018 | $57,086,000 | -0.5% | 877,706 | -1.1% | 0.12% | +1.7% |
| Q4 2017 | $57,361,000 | +6.6% | 887,396 | +3.5% | 0.12% | 0.0% |
| Q3 2017 | $53,799,000 | +6.1% | 857,347 | +2.4% | 0.12% | +0.9% |
| Q2 2017 | $50,691,000 | +18.5% | 837,314 | +1.5% | 0.12% | +16.0% |
| Q1 2017 | $42,768,000 | +21.0% | 824,681 | +3.5% | 0.10% | +11.1% |
| Q4 2016 | $35,338,000 | +0.2% | 796,981 | +7.5% | 0.09% | -7.2% |
| Q3 2016 | $35,277,000 | +6.3% | 741,111 | +1.0% | 0.10% | -1.0% |
| Q2 2016 | $33,185,000 | +14.1% | 733,864 | +3.7% | 0.10% | +8.9% |
| Q1 2016 | $29,073,000 | +12.1% | 707,712 | +4.1% | 0.09% | +8.4% |
| Q4 2015 | $25,936,000 | +15.4% | 679,845 | -0.7% | 0.08% | +9.2% |
| Q3 2015 | $22,481,000 | -52.8% | 684,355 | +0.4% | 0.08% | -50.0% |
| Q2 2015 | $47,649,000 | -15.5% | 681,379 | -17.2% | 0.15% | -6.7% |
| Q1 2015 | $56,386,000 | -8.0% | 823,148 | -1.6% | 0.16% | -8.4% |
| Q4 2014 | $61,290,000 | -1.4% | 836,261 | -3.5% | 0.18% | -4.8% |
| Q3 2014 | $62,178,000 | -9.5% | 866,353 | -8.9% | 0.19% | -7.4% |
| Q2 2014 | $68,730,000 | -3.5% | 950,622 | -1.8% | 0.20% | -4.3% |
| Q1 2014 | $71,206,000 | +3.7% | 967,732 | -2.0% | 0.21% | +3.9% |
| Q4 2013 | $68,675,000 | +1.1% | 987,423 | -4.5% | 0.20% | -3.3% |
| Q3 2013 | $67,901,000 | +0.3% | 1,033,661 | +5.7% | 0.21% | -3.7% |
| Q2 2013 | $67,711,000 | – | 977,499 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |